Global X Genomics & Biotechnology ETF (GNOM)

NASDAQ: GNOM · Real-Time Price · USD
11.10
-0.02 (-0.18%)
Oct 2, 2024, 4:00 PM EDT - Market closed
-0.18%
Assets $83.82M
Expense Ratio 0.50%
PE Ratio n/a
Shares Out 7.46M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return +9.15%
Volume 34,599
Open 11.05
Previous Close 11.12
Day's Range 10.94 - 11.11
52-Week Low 8.63
52-Week High 12.53
Beta 1.10
Holdings 43
Inception Date Apr 5, 2019

About GNOM

Fund Home Page

The Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund that is based on the Solactive Genomics index. The fund tracks an index of global biotech equities, selected and weighted by market cap. GNOM was launched on Apr 5, 2019 and is issued by Global X.

Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol GNOM
ETF Provider Global X
Index Tracked Solactive Genomics Index

Top 10 Holdings

47.35% of assets
Name Symbol Weight
Alnylam Pharmaceuticals, Inc. ALNY 6.78%
Avidity Biosciences, Inc. RNA 5.73%
Natera, Inc. NTRA 4.92%
BioNTech SE BNTX 4.78%
Bio-Techne Corporation TECH 4.46%
Ultragenyx Pharmaceutical Inc. RARE 4.45%
Veracyte, Inc. VCYT 4.40%
Myriad Genetics, Inc. MYGN 4.12%
Qiagen N.V. QGEN 3.89%
Agilent Technologies, Inc. A 3.83%
View More Holdings

News

GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment

GNMO invests across companies benefiting from advancements in the field of genomics within biotechnology. The fund's historical performance has been poor amid volatile stock prices for underlying hold...

6 months ago - Seeking Alpha

Healthcare Dashboard For August And Focus On GNOM

This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value a...

1 year ago - Seeking Alpha

GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now

GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth area, but it will need to get more profitable to ...

1 year ago - Seeking Alpha

GNOM: Healthcare Dashboard For January

Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality.

1 year ago - Seeking Alpha

GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies

The Global X Genomics & Biotechnology ETF tracks the Solactive Genomics Index. It invests in genomics and biotechnology companies. The fund is highly concentrated in one industry, which can negatively...

1 year ago - Seeking Alpha

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

1 year ago - Seeking Alpha

GNOM: ETF Review And Healthcare Dashboard For October

Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages.

2 years ago - Seeking Alpha

Why Now Could Be The Time To Consider Neuroscience Investments

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic...

2 years ago - Seeking Alpha

GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future

GNOM lacks efficient portfolio reshuffling and may not be able to gain from higher alpha-producing stocks in the near future.

2 years ago - Seeking Alpha

Equity Market Cap For Technologically Enabled Innovation Likely To Grow Exponentially

Investment strategies geared to the future evaluate complex dynamics that can evolve rapidly. As innovation's market share has grown, investment capacity - as measured by average days to trade - also ...

3 years ago - Seeking Alpha

ETF Battles: ARKG Vs IDNA Vs GNOM

Join us for a triple-header to determine the best genomics biotech ETF!

Other symbols: ARKGIDNA
3 years ago - ETFcom

Global X Genomics & Biotechnology ETF: Targeted Fund Provides Strong Growth And Steady Dividend

Global X Genomics & Biotechnology ETF is a passive ETF with a healthcare sector focus.

3 years ago - Seeking Alpha

Biotechs Ready To Roar

Biotechs are ready to march forcefully higher after a lengthy consolidation. Approval of Biogen's Alzheimer's treatment creates a bonanza for neurodegenerative-focused companies and the overall biotec...

3 years ago - Seeking Alpha

ETF Battles: ARKG Vs GNOM

Which biotech/genomics ETF is the better play?

Other symbols: ARKG
3 years ago - ETFcom

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

3 years ago - Seeking Alpha

Moving Beyond COVID In Biopharma

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,...

3 years ago - Seeking Alpha

Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up

Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped 4%...

Other symbols: IBBXBI
4 years ago - Market Watch

An ETF For Every Theme: COVID-19 Lightning Round With Global X (Podcast Transcript)

The COVID-19 pandemic has created a massive divergence in performance among thematic ETFs.

Other symbols: BOTZDIVEBIZHEROSDIV
4 years ago - Seeking Alpha

Three tech subgroups can keep climbing despite the sector's record run, ETF analyst says

Investors should consider buying into genomics, cloud computing and video gaming ETFs as tech trades near records, Global X's Jay Jacobs says.

Other symbols: CLOUHEROVGTXLK
4 years ago - CNBC

An ETF For Every Theme: COVID-19 Lightning Round With Global X (Podcast)

An ETF For Every Theme: COVID-19 Lightning Round With Global X (Podcast)

4 years ago - Seeking Alpha

3 Genomics ETFs Worth Jumping For

The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are deliv...

Other symbols: ARKG
4 years ago - Benzinga

Themes For Defensive Positioning

We believe cannabis, infrastructure, genomics and longevity are a few themes that could not only withstand a potential recession, but also perhaps thrive.

Other symbols: PAVE
5 years ago - Seeking Alpha

This High Growth ETF May Not Be As Pricey As You Think

When it comes to growth stocks, investors often expect they will pay up to access that.

5 years ago - Benzinga